Document Type

Article

Publication Date

April 2022

Patent Number

11306059

CPC

C07D 211/90, C07C 233/88

Abstract

Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.

Application Number

16/758991

Assignees

University of South Florida

Filing Date

10/25/2018

Share

COinS